ALT lab range refers to the normal reference interval for alanine aminotransferase, a liver enzyme measured in blood tests to assess liver health. Levels typically fall between 7 and 40 units per liter (U/L) in adults, though labs may use slightly different thresholds based on sex and methodology.
Alanine aminotransferase is primarily found in liver cells. When liver tissue is damaged, ALT leaks into the bloodstream. Elevated ALT levels signal hepatocellular injury, making this test a key indicator in diagnosing liver disease. The test is often included in routine metabolic panels and is especially useful for detecting early-stage liver issues before symptoms appear.
Values above 40 U/L are considered elevated and may prompt further evaluation. Persistent elevations beyond 100 U/L strongly suggest underlying liver pathology. The American Association for the Study of Liver Diseases (AASLD) notes that ALT levels above 50 U/L warrant investigation into causes such as fatty liver, viral hepatitis, or medication-induced injury.
ALT lab range is determined through a standard venous blood draw, usually performed in the morning after fasting for 8-12 hours. The sample is sent to a clinical laboratory where automated analyzers measure enzyme activity using spectrophotometry. Results are reported in U/L and compared against the lab's established reference range.
Reference ranges vary slightly between laboratories due to differences in assay calibration and population norms. For example, Mayo Clinic uses a range of 7-56 U/L for men and 5-36 U/L for women. The University of California San Diego Health System reports a range of 7-40 U/L for both sexes. These differences show the importance of interpreting results within the context of the specific lab's standards.
A single elevated ALT value does not confirm liver disease. Repeat testing over time is essential. A rise from 35 to 80 U/L over two weeks suggests progressive injury, while a transient spike may result from recent exercise, alcohol intake, or certain medications.
Abnormal ALT results fall into three categories: mild, moderate, and severe elevation:
| Level (U/L) | Interpretation | Common Causes |
|---|---|---|
| 40-100 | Mild elevation | Fatty liver, statin use, mild viral hepatitis |
| 100-500 | Modest to marked elevation | Alcoholic liver disease, autoimmune hepatitis, drug toxicity |
| >500 | Severe elevation | Acute viral hepatitis (e.g., hepatitis B), ischemic liver injury, Wilson's disease |
ALT levels rarely exceed 1,000 U/L unless there is acute liver necrosis. A patient with acute hepatitis B infection once reached 2,300 U/L during a flare-up, which resolved after antiviral treatment. This level is uncommon but indicates significant cellular damage.
ALT is often interpreted alongside AST (aspartate aminotransferase). The ratio of AST to ALT helps differentiate causes: in alcoholic liver disease, AST is typically higher than ALT (AST/ALT > 1), whereas in non-alcoholic fatty liver disease (NAFLD), ALT is usually higher (AST/ALT < 1).
Many assume that elevated ALT always means liver disease. In reality, ALT can rise due to non-hepatic factors. A 2021 study published in Clinical Chemistry found that 15% of patients with ALT levels above 50 U/L had no evidence of liver pathology upon imaging and biopsy. Causes included muscle trauma, hyperthyroidism, and even recent strenuous exercise.
Another misconception is that ALT levels correlate directly with disease severity. A patient with chronic hepatitis C may have ALT levels of 60 U/L for years without fibrosis progression, while another with NAFLD may show rapid fibrosis despite only mildly elevated ALT. Therefore, ALT is a screening tool-not a standalone diagnostic.
Some labs report "normal" ranges up to 50 U/L. A result of 48 U/L may be flagged as "within normal limits," but this misses subtle elevations that could precede clinical disease. The National Institutes of Health (NIH) recommends using lower thresholds-such as 30 U/L-for early detection in high-risk populations like those with obesity or type 2 diabetes.
A 45-year-old woman with a BMI of 32 presents with fatigue. Her routine blood work shows ALT at 78 U/L and AST at 42 U/L. The lab's reference range is 7-40 U/L. She denies alcohol use and takes no medications affecting the liver.
Her elevated ALT, combined with obesity and fatigue, raises concern for non-alcoholic fatty liver disease (NAFLD). An ultrasound confirms hepatic steatosis. She is advised to adopt a Mediterranean diet and increase physical activity. After six months, her ALT drops to 32 U/L, indicating improvement.
This case illustrates how ALT lab range serves as a red flag for early liver dysfunction. Without this test, NAFLD might remain undetected until advanced fibrosis develops.
Elevated ALT persists in 10-15% of adults in the U.S. population, according to the Centers for Disease Control and Prevention (CDC). Most cases are benign, but persistent elevations require follow-up. The American Gastroenterological Association advises evaluating ALT levels above 50 U/L with imaging (ultrasound or FibroScan) and additional labs, including hepatitis serologies and ferritin.
If ALT remains elevated after three months, referral to a hepatologist is recommended. Early intervention prevents progression to cirrhosis or hepatocellular carcinoma.
ALT lab range is not a diagnosis but a window into liver health. Recognizing its limits and context ensures accurate interpretation and timely care.